Simplify Logo

Full-Time

Senior Rust Software Developer

Confirmed live in the last 24 hours

Q Bio

Q Bio

11-50 employees

Offers preventive health assessments and monitoring

Data & Analytics
Hardware
Biotechnology

Compensation Overview

$160k - $190kAnnually

+ Equity + Stock Options

Mid, Senior

San Carlos, CA, USA

Category
Backend Engineering
Software Engineering
Required Skills
Rust
Requirements
  • Prior experience with systems programming in a compiled language
  • Solid programming experience in Rust (two years minimum), comfortable with idiomatic rust patterns described in “the book,” ownership, lifetimes, futures, testing, and shipping crates.
  • Strong sense of ownership and a passion for solving technical challenges by writing code
Responsibilities
  • helping to build QBio's whole body scanner control and data acquisition software (which is written in Rust), working closely with the scientists and engineers across the team

Q.bio focuses on preventive medicine by identifying early signs of disease before symptoms arise, which allows for timely interventions and improved health outcomes. The main product is the Q Exam, a comprehensive health assessment that takes about an hour and collects data from blood, saliva, urine, vitals, and whole-body MRI scans. This information is stored securely in a personalized BioVault and can be accessed through the Q Dashboard, which is designed for telemedicine, enabling users to share their health data with healthcare professionals globally. Q.bio differentiates itself from competitors by offering a subscription-based model that provides regular health assessments and continuous monitoring for individuals, as well as partnerships with clinicians to enhance their practices with data-rich preventive medicine. The goal of Q.bio is to empower clients to take control of their health through detailed, data-driven insights that facilitate informed decision-making.

Company Stage

Series B

Total Funding

$76M

Headquarters

San Carlos, California

Founded

2015

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

6%

2 year growth

16%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $27M in funding for the Mark I MRI scanner demonstrates strong investor confidence and provides resources for technological advancements.
  • The launch of Tensor Field Mapping technology positions Q Bio at the forefront of medical imaging innovation, potentially revolutionizing diagnostic accuracy and personalized medicine.
  • Partnerships with prominent investors like Khosla Ventures and Andreessen Horowitz enhance Q Bio's credibility and market reach.

What critics are saying

  • The high cost and complexity of developing and maintaining advanced MRI technology could strain financial resources and operational capacity.
  • The preventive healthcare market is highly competitive, requiring Q Bio to continuously innovate to maintain its edge.

What makes Q Bio unique

  • Q Bio's Tensor Field Mapping technology offers quantitative, harmonized imaging data, setting it apart from traditional qualitative MRI scans.
  • The Q Exam provides a comprehensive health assessment in just one hour, combining multiple data sources into a single, detailed snapshot of an individual's health.
  • Q Bio's subscription-based model for both individuals and clinicians ensures continuous monitoring and integration of preventive medicine into everyday healthcare.